BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

177 related articles for article (PubMed ID: 37587335)

  • 21. Proliferation in the normal FTE is a hallmark of the follicular phase, not BRCA mutation status.
    George SH; Milea A; Shaw PA
    Clin Cancer Res; 2012 Nov; 18(22):6199-207. PubMed ID: 22967960
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Mutant p53 expression in fallopian tube epithelium drives cell migration.
    Quartuccio SM; Karthikeyan S; Eddie SL; Lantvit DD; Ó hAinmhire E; Modi DA; Wei JJ; Burdette JE
    Int J Cancer; 2015 Oct; 137(7):1528-38. PubMed ID: 25810107
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Loss of PAX8 in high-grade serous ovarian cancer reduces cell survival despite unique modes of action in the fallopian tube and ovarian surface epithelium.
    Rodgers LH; Ó hAinmhire E; Young AN; Burdette JE
    Oncotarget; 2016 May; 7(22):32785-95. PubMed ID: 27129161
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Microscopic and early-stage ovarian cancers in BRCA1/2 mutation carriers: building a model for early BRCA-associated tumorigenesis.
    Yates MS; Meyer LA; Deavers MT; Daniels MS; Keeler ER; Mok SC; Gershenson DM; Lu KH
    Cancer Prev Res (Phila); 2011 Mar; 4(3):463-70. PubMed ID: 21278312
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Epithelially Restricted Interferon Epsilon Protects Against Colitis.
    de Geus ED; Volaric JS; Matthews AY; Mangan NE; Chang J; Ooi JD; de Weerd NA; Giles EM; Hertzog PJ
    Cell Mol Gastroenterol Hepatol; 2024; 17(2):267-278. PubMed ID: 37879406
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Identification of a preneoplastic gene expression profile in tubal epithelium of BRCA1 mutation carriers.
    Press JZ; Wurz K; Norquist BM; Lee MK; Pennil C; Garcia R; Welcsh P; Goff BA; Swisher EM
    Neoplasia; 2010 Dec; 12(12):993-1002. PubMed ID: 21170264
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Lessons from BRCA: the tubal fimbria emerges as an origin for pelvic serous cancer.
    Crum CP; Drapkin R; Kindelberger D; Medeiros F; Miron A; Lee Y
    Clin Med Res; 2007 Mar; 5(1):35-44. PubMed ID: 17456833
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Transformation of the fallopian tube secretory epithelium leads to high-grade serous ovarian cancer in Brca;Tp53;Pten models.
    Perets R; Wyant GA; Muto KW; Bijron JG; Poole BB; Chin KT; Chen JY; Ohman AW; Stepule CD; Kwak S; Karst AM; Hirsch MS; Setlur SR; Crum CP; Dinulescu DM; Drapkin R
    Cancer Cell; 2013 Dec; 24(6):751-65. PubMed ID: 24332043
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Ovarian pathology in risk-reducing salpingo-oophorectomies from women with BRCA mutations, emphasizing the differential diagnosis of occult primary and metastatic carcinoma.
    Rabban JT; Barnes M; Chen LM; Powell CB; Crawford B; Zaloudek CJ
    Am J Surg Pathol; 2009 Aug; 33(8):1125-36. PubMed ID: 19440148
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Risk factors for a serous cancer precursor ("p53 signature") in women with inherited BRCA mutations.
    Saleemuddin A; Folkins AK; Garrett L; Garber J; Muto MG; Crum CP; Tworoger S
    Gynecol Oncol; 2008 Nov; 111(2):226-32. PubMed ID: 18718648
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Fallopian tube origin of supposed ovarian high-grade serous carcinomas.
    Diniz PM; Carvalho JP; Baracat EC; Carvalho FM
    Clinics (Sao Paulo); 2011; 66(1):73-6. PubMed ID: 21437439
    [TBL] [Abstract][Full Text] [Related]  

  • 32. The peritoneal tumour microenvironment of high-grade serous ovarian cancer.
    Leinster DA; Kulbe H; Everitt G; Thompson R; Perretti M; Gavins FN; Cooper D; Gould D; Ennis DP; Lockley M; McNeish IA; Nourshargh S; Balkwill FR
    J Pathol; 2012 Jun; 227(2):136-45. PubMed ID: 22322968
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Microarray analysis of differentially expressed genes in ovarian and fallopian tube epithelium from risk-reducing salpingo-oophorectomies.
    Veskimäe K; Staff S; Tabaro F; Nykter M; Isola J; Mäenpää J
    Genes Chromosomes Cancer; 2015 May; 54(5):276-87. PubMed ID: 25706666
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Histopathological characteristics of BRCA1- and BRCA2-associated intraperitoneal cancer: a clinic-based study.
    Piek JM; Torrenga B; Hermsen B; Verheijen RH; Zweemer RP; Gille JJ; Kenemans P; van Diest PJ; Menko FH
    Fam Cancer; 2003; 2(2):73-8. PubMed ID: 14574155
    [TBL] [Abstract][Full Text] [Related]  

  • 35. High-grade serous ovarian cancer arises from fallopian tube in a mouse model.
    Kim J; Coffey DM; Creighton CJ; Yu Z; Hawkins SM; Matzuk MM
    Proc Natl Acad Sci U S A; 2012 Mar; 109(10):3921-6. PubMed ID: 22331912
    [TBL] [Abstract][Full Text] [Related]  

  • 36. The fallopian tube as the origin of high grade serous ovarian cancer: review of a paradigm shift.
    Reade CJ; McVey RM; Tone AA; Finlayson SJ; McAlpine JN; Fung-Kee-Fung M; Ferguson SE
    J Obstet Gynaecol Can; 2014 Feb; 36(2):133-140. PubMed ID: 24518912
    [TBL] [Abstract][Full Text] [Related]  

  • 37. High grade serous ovarian carcinomas originate in the fallopian tube.
    Labidi-Galy SI; Papp E; Hallberg D; Niknafs N; Adleff V; Noe M; Bhattacharya R; Novak M; Jones S; Phallen J; Hruban CA; Hirsch MS; Lin DI; Schwartz L; Maire CL; Tille JC; Bowden M; Ayhan A; Wood LD; Scharpf RB; Kurman R; Wang TL; Shih IM; Karchin R; Drapkin R; Velculescu VE
    Nat Commun; 2017 Oct; 8(1):1093. PubMed ID: 29061967
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Murine Oviductal High-Grade Serous Carcinomas Mirror the Genomic Alterations, Gene Expression Profiles, and Immune Microenvironment of Their Human Counterparts.
    McCool KW; Freeman ZT; Zhai Y; Wu R; Hu K; Liu CJ; Tomlins SA; Fearon ER; Magnuson B; Kuick R; Cho KR
    Cancer Res; 2020 Feb; 80(4):877-889. PubMed ID: 31806642
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Molecular evidence for putative tumour suppressor genes on chromosome 13q specific to BRCA1 related ovarian and fallopian tube cancer.
    Jongsma AP; Piek JM; Zweemer RP; Verheijen RH; Klein Gebbinck JW; van Kamp GJ; Jacobs IJ; Shaw P; van Diest PJ; Kenemans P
    Mol Pathol; 2002 Oct; 55(5):305-9. PubMed ID: 12354934
    [TBL] [Abstract][Full Text] [Related]  

  • 40. IFN-γ from lymphocytes induces PD-L1 expression and promotes progression of ovarian cancer.
    Abiko K; Matsumura N; Hamanishi J; Horikawa N; Murakami R; Yamaguchi K; Yoshioka Y; Baba T; Konishi I; Mandai M
    Br J Cancer; 2015 Apr; 112(9):1501-9. PubMed ID: 25867264
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.